Allegaert, K.; Rayyan, M.; Cossey, V.; Van Geet, C. Subcutaneous Palivizumab (Synagis®) Administration in an Infant With Congenital Type 2B Von Willebrand Disease. J Pediatr Neonat Individual Med 2015, 4, e040104.